Intraocular Cytokine in Recurrence of Polypoidal Choroidal Vasculopathy
- Status
- UNKNOWN
- Phase
- PHASE4
Clinical Trials Related to Ranibizumab
Related studies linked through entity extraction aliases.
Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety
- Status
- COMPLETED
- Phase
- PHASE4
24 Week Study to Compare Systemic VEGF-levels of Ranibizumab and Aflibercept in DME.
- Status
- WITHDRAWN
- Phase
- PHASE4
Comparison of PDT Combination With Ranibizumab vs. Ranibizumab Monotherapy in Persistent PCV With Initial Loading Dose
- Status
- UNKNOWN
- Phase
- PHASE4
A Phase I/II Trial for Intravitreous Treatment of Severe Ocular Von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist Ranibizumab
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Intravitreal Injection of Ranibizumab Versus Sham Before Vitrectomy in Patients With Proliferative Diabetic Retinopathy
- Status
- COMPLETED
- Phase
- NA
Functional and Structural Outcomes in Neovascular Age-related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE4
Safety and Efficacy of Two Regimens of Ranibizumab 0.5 mg in Chinese Patients With Neovascular AMD
- Status
- UNKNOWN
- Phase
- PHASE4
Intravitreal Ranibizumab and TA Combination Therapy vs. Ranibizumab Monotherapy in Polypoidal Choroidal Vasculopathy
- Status
- UNKNOWN
- Phase
- PHASE4
Efficacy and Safety Study of Squalamine Ophthalmic Solution in Subjects With Neovascular AMD
- Status
- UNKNOWN
- Phase
- PHASE3
Cytokeratin 8 Level in Age-related Macular Degeneration
- Status
- COMPLETED
- Phase
- N/A
A Study of Faricimab (RO6867461) in Participants With Center-Involving Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE2
A Study in Patients With Neovascular Age Related Macular Degeneration or Macular Edema Secondary To Retinal Vein Occlusion to Evaluate Usability of the Ranibizumab (Lucentis®) Prefilled Syringe (PFS)
- Status
- COMPLETED
- Phase
- PHASE3
Influence of Diabetes Control on Treatment of Diabetic Macular Edema With Ranibizumab
- Status
- TERMINATED
- Phase
- PHASE4
Intravitreal Ranibizumab Injection as Adjuvant in the Treatment of Postvitrectomy Diabetic Vitreous Hemorrhage Accompanied by Neovascular Glaucoma
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy of Ranibizumab Therapy With Aflibercept in Patients With Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE4
Intravitreal Aflibercept or Ranibizumab for Rubeosis Iridis
- Status
- COMPLETED
- Phase
- PHASE3
Rainbow Extension Study
- Status
- COMPLETED
- Phase
- PHASE3
CANadian Study in Patients With Wet AMD, Evaluating the Efficacy and Safety of Switching From Intravitreal Aflibercept to RanIbizumab
- Status
- WITHDRAWN
- Phase
- PHASE4
Study of Squalamine Lactate for the Treatment of Macular Edema Related to Retinal Vein Occlusion
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2